Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.4 (
RNase H
)
2,751
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Our earlier studies have shown that the mRNA from many bacterial species, including Escherichia coli and Bacillus subtilis, is extensively polyadenylated, but with shorter poly(A) segments than those associated with eukaryotic mRNA. In this paper, we show that about 40% of the mRNA for the tryptophan synthetase alpha-subunit (TrpA) of E. coli carries a 3'-terminal polyadenylate sequence of 15 to 20 residues. This conclusion was supported by several independent lines of evidence. About 40% of
trpA
mRNA bound to oligo(dT)-cellulose at high ionic strength and was eluted with water. Treatment with
RNase H
in the presence of oligo(dT)12-18 destroyed the ability of
trpA
mRNA to bind to oligo(dT)-cellulose, presumably through the degradation of the poly(A) tract.
trpA
mRNA could be used as template for complementary DNA synthesis with reverse transcriptase in a reaction that was absolutely dependent on oligo(dT)12-18 as primer. The identity of the cDNA product as a complement to
trpA
mRNA was established by specific hybridization. In addition, it was possible to synthesize polyadenylated
trpA
mRNA in toluene-permeabilized cells of E. coli transformed with a recombinant plasmid carrying the
trpA
gene. In view of the fact that the
trpA
gene and its 3'-untranslated region contain no continuous deoxyadenylate sequences larger than five nucleotides, one can conclude that the polyadenylate moiety is added post-transcriptionally.
...
PMID:3'-terminal polyadenylate sequences of Escherichia coli tryptophan synthetase alpha-subunit messenger RNA. 244 21